Pancreatic Cancer Research

ResearcherFujian Medical UniversityActive in the last 2 years

Haitao Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1639-4089; OpenAlex author ID A5100454575. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
33
Papers, trials and grants by year

2026: 8 papers

Papers 8

  1. Corrigendum to "High glucose-induced mitochondrial fission drives pancreatic cancer progression through the H3K18la/TTK/BUB1B signal pathway" [Cellular Signall… Co-author DOI 10.1016/j.cellsig.2026.112467↗
  2. Dual blockade of PD-1 and NKG2A prevents NK cell senescence and reprograms the immunosuppressive microenvironment in pancreatic cancer. Co-author DOI 10.1016/j.celrep.2026.117583↗
  3. Chinese expert consensus on precision testing and molecular diagnosis of pancreatic cancer (2025). Co-author DOI 10.1038/s41416-026-03522-x↗
  4. AI-driven tumor heterogeneity quantification and survival prediction in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41746-026-02979-7↗
  5. Safety and oncologic efficacy of robotic surgery compared to open surgery after neoadjuvant therapy for pancreatic cancer. First author DOI 10.1186/s12893-026-03942-9↗
  6. Interpretable Radiomics-Based Machine Learning for Non-Invasive Prediction of Tertiary Lymphoid Structure Status in Pancreatic Ductal Adenocarcinoma Co-author DOI 10.21203/rs.3.rs-10027511/v1↗
  7. The association between periodontal disease and pancreatic cancer: epidemiology, mechanisms, and implications for clinical management. Co-author DOI 10.3389/fcimb.2026.1817579↗
  8. Prognostic value and immunological significance of t-cell proliferation regulators in pancreatic cancer: a novel predictive model. Co-author DOI 10.3389/fmed.2026.1800810↗

Closest collaborators

The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhiyong Liang · 2 shared papers, 2026 · strength 0.47
  2. Yun Zhong · 1 shared paper, 2026 · strength 0.29
  3. Binbin Wang · 1 shared paper, 2026 · strength 0.29
  4. Wei Wei · 1 shared paper, 2026 · strength 0.29
  5. Shangeng Weng · 1 shared paper, 2026 · strength 0.29
  6. Fadian Ding · 1 shared paper, 2026 · strength 0.29
  7. Wenyi Guo · 1 shared paper, 2026 · strength 0.28
  8. Jianwei Xu · 1 shared paper, 2026 · strength 0.28
  9. Xuan Lin · 1 shared paper, 2026 · strength 0.27
  10. S H E N G H Zhou · 1 shared paper, 2026 · strength 0.27
  11. Pengyu Li · 1 shared paper, 2026 · strength 0.25
  12. Min Dai · 1 shared paper, 2026 · strength 0.25
  13. Wen-Jing Liu · 1 shared paper, 2026 · strength 0.25
  14. Huadan Xue · 1 shared paper, 2026 · strength 0.25
  15. Wei Li · 1 shared paper, 2026 · strength 0.23
  16. Chunyi Hao · 1 shared paper, 2026 · strength 0.23
  17. Guang Tan · 1 shared paper, 2026 · strength 0.23
  18. Ke Cheng · 1 shared paper, 2026 · strength 0.23
  19. Liwei Wang · 1 shared paper, 2026 · strength 0.23
  20. Huanji Xu · 1 shared paper, 2026 · strength 0.23
  21. Dan Cao · 1 shared paper, 2026 · strength 0.23
  22. Jianhui Wu · 1 shared paper, 2026 · strength 0.23
  23. Jiujie Cui · 1 shared paper, 2026 · strength 0.23
  24. Kuirong Jiang · 1 shared paper, 2026 · strength 0.23
  25. Qi Li · 1 shared paper, 2026 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.